Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/4183Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Madhusudhan, G | - |
| dc.contributor.author | Naidu, K Chinnam | - |
| dc.contributor.author | Kumar, B Anand | - |
| dc.contributor.author | Satyanarayana, R | - |
| dc.contributor.author | Balraju, V | - |
| dc.date.accessioned | 2009-05-13T07:29:13Z | - |
| dc.date.available | 2009-05-13T07:29:13Z | - |
| dc.date.issued | 2009-05 | - |
| dc.identifier.issn | 0376-4699 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/4183 | - |
| dc.description | 741-745 | en_US |
| dc.description.abstract | Carvedilol is prepared by different synthetic approaches. Almost in all the approaches the major impurities that are known in the literature A, B, C, D and E are listed in European pharmacopoeia. The control of pharmaceutical impurities is currently a critical issue to the pharmaceutical industry. In this publication, a description of these impurities and their origins in Carvedilol process are presented along with the preparation of impurity A. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.source | IJC-B Vol.48B(05) [May 2009] | en_US |
| dc.subject | Carvedilol | en_US |
| dc.subject | impurities | en_US |
| dc.subject | β-adrenergic receptor | en_US |
| dc.title | Synthesis of impurity A in Carvedilol: a β-adrenergic receptor | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.48B(05) [May 2009] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 48B(5) 741-745.pdf | 88.92 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.